-
-
-
-
-
-
-
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management
-
-
-
-
-
-
-
Indaba Capital Announces Sale of AST Revolution to Bruker
-
-
-
-
-
-
-
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics
-
-
-
-
-
-
-
Bruker Announces First Quarter 2025 Preliminary Revenue
-
-
-
-
-
-
-
Barclays Assumes Bruker (BRKR) at Overweight
-
-
-
-
-
-
-
Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference
-
-
-
-
-
-
-
Stifel on Bruker (BRKR) Nanostring Deal: 'This outlook is useful in that it frames the conversation on expectations going forward'
-
1,182,407 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

